The mushroom has evolved. Building on millennia of psychoactive, functional and nutritional use, the new breed of mushroom company, the latest research and the most radical ideas are heralding a new age.

We'll look in detail at these amazing developments, deep dive into the science and present the leading ventures in the medicinal and functional mushroom space.

TICKET PURCHASE INCLUDES LIFETIME ACCESS TO RECORDINGS

CONFERENCE TIMES & FORMAT

Panels and keynotes will run for 45 minutes, with a 15 minute Q&A session afterwards. The conference will begin at 17:00 (GMT) / 12:00(EST) / 09:00 (PST) each day. You will be sent login and platform details with your ticket. Check agenda here.

The whole conference will be recorded and will be available to all ticket holders to enable attendees to make the most of the experience.

Presenting Sponsors

Psygen Labs Inc (“Psygen”) is a Calgary-based company specializing in the synthetic manufacture of psychedelic medicines. The company provides non-exclusive access to psychedelic drug products for clinical research, therapeutic applications and is well positioned to be a lead supplier for the emerging commercial market.

Psygen sponsored a Licensed Dealer at the University of Alberta to receive a license for the manufacture, sale, import, export, and analysis of psilocybin, MDMA, DMT, LSD, 2C-B, and mescaline. Our chemists and manufacturing lab currently reside at the University of Alberta where sales are brokered via our Licensed Dealer, Dr. Raimar Löbenberg. Psygen has applied to Health Canada for a corporate Dealer’s License which will allow them to manufacture, possess, sell, import, export and analyze psychedelic substances. The company is actively developing and constructing their 6000sq/ft lab capable of large-scale synthesis, formulation and distribution of the psychedelic compounds mentioned above. Psygen is the leader in psychedelic supply chain solutions and is committed to supporting the research renaissance in the clinical treatment of a wide variety of mental health issues.

Gold Sponsors

MagicMed Industries intends to partner with pharmaceutical and other companies to develop psychedelic-derived medicinal and licit consumer goods products. MagicMed’s molecular derivatives library, the Psybrary™ is anticipated to be an essential building block from which industry can develop new patented products. The initial focus of the Psybrary™ is on psilocybin, and is expected to be opportunistically expanded to other psychedelics like MDMA, ketamine, ibogaine, mescaline, and ayahuasca.

Silver Sponsors

Wake Network is a vertically integrated fungi medicine company focused on addressing the most critical mental health challenges facing the world today and tomorrow. The Wake Network’s industry leading cultivation and approach to novel clinical research with fungus based substances is all backed by their compliance focused virtual wellness platform.

The Wake Network is a decentralized international fungus company with operating facilities in Canada, Jamaica and the USA. The Wake Network recognizes that employees are at the core of its success and takes pride in a corporate culture that emphasizes inclusiveness, collaboration, and diversity.

Our employees come from a wide range of backgrounds, each bringing their own unique skills and talents to the table, working together to continue our growth.

Pilz Bioscience Corp. (“Pilz”) is a biotechnology company developing medicinal psychedelics for neuroinflammatory conditions with a significant cognitive component and high unmet therapeutic needs. The initial focus is on Autism Spectrum Disorder (ASD). The company intends to leverage a unique systems-level scientific approach that integrates inflammation, oral/gut/brain axis, and behavior. Pilz aims to lead the global effort in design of effective and comprehensive diagnostic/monitoring programs and first-in-class therapeutics.

Bronze Sponsors

ACS Pharmacology & Translational Science is a peer-reviewed journal from the American Chemical Society and ACS Publications. Its editorial team is preparing to publish a special issue on psychedelics for treating mental illness in early 2021 under the supervision of guest editor, Assistant Professor David Olson of the University of California, Davis, Department of Chemistry and Department of Biochemistry & Molecular Medicine.

ACS Pharmacology & Translational Science publishes high-quality, innovative research across the broad spectrum of biological sciences—from basic and molecular sciences to translational preclinical studies. Its editors also consider clinical studies that address novel mechanisms of action and methodological papers that provide innovation and advance translation.

ACS Pharmacology & Translational Science has no charges or fees to submit a manuscript or to publish an article under the traditional subscription model (non-open-access). That means no author charges, page charges, processing charges, or color charges. It is a hybrid journal that allows authors to choose to publish their article open access. There is an article publication charge (APC) to publish an article open access.

Editor-in-Chief Craig W. Lindsley invites you to submit your next manuscript to ACS Pharmacology & Translational Science.

Learn more about the journal’s scope and how to submit a manuscript.

Social Sponsors

Empyrean is a science-driven company focused on developing and marketing advanced evidence-based orthomolecular products including Myco Botanicals and Entheogens. Empyrean supports its customers’ quest with products that harness the medicinal value of natural full-spectrum extracts, the benefits of microdosing select ingredients, and the synergy created by blending them.

Dr. Jillian Hagel

COO | MagicMed Industries Inc.

Dr. Jillian Hagel received her PhD in the field of natural products biochemistry in 2010. She acts as COO for MagicMed Industries, leading its Science team's laser focus on delivering partner milestones, general operations including science platform coordination, and patent filings. Dr. Hagel has previously held COO and Vice President roles in the biotechnology industry.

Kelan Thomas, PharmD, MS

Associate Professor of Clinical Sciences | Touro University California

Kelan Thomas, PharmD, MS, is an associate professor and board-certified psychiatric pharmacist with outpatient behavioral health practice sites in San Francisco and Oakland. He completed undergraduate chemistry/pharmacology at Duke University, a PharmD at UC San Francisco, and a Clinical Research MS at University of Michigan. He has completed clinical pharmacy residencies at University of Michigan and University of Southern California. His research is related to psychopharmacology, adverse drug reactions and pharmacogenomics with the goal of optimizing mental health pharmacotherapy for psychiatric clients. More recently he completed the California Institute of Integral Studies (CIIS) Certificate in Psychedelic-Assisted Therapies and Research training program and started collaborating on psilocybin & MDMA clinical trials at UC San Francisco.

Olga Chernoloz

Chief Scientific Officer | The Wake Network

With a Ph.D. in Neuroscience Olga has held a number of roles in clinical trial management, drug development, biotech, and pharmaceutics. As a trained neuropharmacologist and a registered pharmacist Dr. Chernoloz, leads R&D programs, runs feasibility analyses and optimizes business development strategy taking into consideration scientific and regulatory underpinnings. She has developed and delivered educational modules for medical and adult psychedelic space in both academic and business settings. Prior to pivoting into the cannabinoid and psychedelic field, Olga specialized in mental health research authoring a number of original research articles and a chapter in an instructional book on Neurobiology of Mood Disorders.

Nick Murray

Co-Founder & CEO | The Wake Network

Nick got into fungi medicine and eastern healing when his girlfriend at the time was diagnosed with Hodgkin’s Lymphoma. He turned to turkey tail mushrooms which helps strengthen the immune system to fight cancer. He is now a full time biohacker and has been building technology companies and ventures for 2 decades. Nick has always been intrigued by technology and how it can be leveraged to enhance people’s everyday lives.

Pauline Terri Smith

Chief Mycologist | The Wake Network

Wake Jamaica is a Joint Venture subsidiary run by Pauline and Ronald Smith, widely regarded as the treasures of mushroom cultivation in Jamaica. Pauline founded and leads the Network of Women for Food Security and the Association of Mushroom Producers. She grows both Medicinal and Psilocybin mushrooms for all of our products and retreats.

Marshall Tyler

Director of Research | Field Trip Psychedelics Inc.

Marshall is a scientist with a deep interest in psychoactive molecules. He spent his academic career exploring the intersection of chemistry and biology in an attempt to unravel the molecular basis of neuropsychiatric disorders. His passion lies in guiding research to arrive at a deeper understanding of consciousness with the ultimate goal of enhancing wellbeing. He currently conducts research on psychoactive mushrooms at Field Trip Psychedelic's lab in Jamaica.

Marvin Hausman MD

Chief Medical Officer | Pilz Bioscience Corp

Dr. Marvin Hausman received his Medical Doctor Degree from New York University School of Medicine. He is an Immunologist and Board Certified Urological Surgeon. Dr. Hausman has over 30 years of drug research and development experience with various pharmaceutical companies including Bristol-Myers International, Mead-Johnson Pharmaceutical Co., E.R. Squibb and Medco Research. An accomplished executive with domestic and international experience who is also on the Alumni Board of Governors of NYU Grossman School of Medicine.

Dr. Hyder A. Khoja

Founder and CSO | Transcendent Therapeutics, Inc,

Dr. Khoja is a stellar and accomplished Global Life Science Executive who brings sagacious and vibrant entrepreneurship within the high-tech scientific sector. He is a trusted and recognized global leader in Psychedelics, Salubrious & Sanative Drug Development. He possesses comprehensive knowledge of life sciences focusing on Mental Health within Pharma, Nutraceutical and Psychedelic industries on a broader vision to drug discovery for Remedial therapeutics. His expertise lies in translating ideas into action, including innovation, commercialization, and knowledge mobilization.

Dennis McKenna Ph.D.

Ethnopharmacologist, author founding board member at the Heffter Research Institute | Principal Founder The McKenna Academy

Of the many problems we face on this planet, one man is sure that the solution resides in our reconnection with Nature. Dennis McKenna has, for many years, utilized his background in science and academia to discover and teach others about the potential of both psilocybin and ayahuasca—two psychedelic drugs that show promise in the areas of mental health, end of life care, and addiction. He earned his Ph.D. from the University of British Columbia in 1984, taught courses at the Center for Spirituality and Healing at the University of Minnesota, and moved on in 2017 to found the BC-based McKenna Academy for Natural Philosophy, a "modern mystery school" with a primary mission of education. The McKenna Academy, says Dennis, will be the first psychedelic university in 1500 years.

Daniel Shankin

Founder | Mt. Tam Psychedelic Integration

Daniel Shankin (AKA Sitaram Das) is the founder of Mt. Tam Psychedelic Integration, which supports individuals who are exploring their consciousness for spiritual growth and transformational healing. A yoga and meditation teacher for over 20 years, Daniel has dedicated his life to the cultivation of clarity, resilience, and heart. He uses tools from a wide variety of traditions to help his clients to develop powerful personal practices for psychedelic preparation and integration.

Jme Bonfiglio

Founder and Owner | Wholesun Wellness

Jme Bonfiglio believes in the power of mushrooms after decades of personal and professional experience. She founded WholeSun Wellness in 2017 to offer clinically-potent mushroom extracts with verifiable therapeutic levels of naturally-occurring medicinal compounds to consumers, retailers, and clinicians. As a formulator her custom blends can be found in conventional and holistic medical clinics across the country. She is currently creating new formulas with psilocybin as she builds the largest vertically-integrated medicinal mushroom operation in North America, which will pave the way for psilocybin manufacturing.

Tonya Papanikolov

Founder and CEO | Rainbo

Tonya Papanikolov (B.Sc, CNP) is a Holistic Nutritionist, educator, yogi and the Founder and CEO of Rainbo. Rainbo is a sustainable medicinal mushroom company offering supplements and functional foods. The company is rooted in Tonya's passion and vision for healing people and the planet with fungi. Years ago, Tonya began using medicinal mushrooms to heal a health condition and experienced the mind, body, spirit elevating properties of fungi which lead her to study mycology, mycotherapy and mycoremediation.

Mark McCoy

Co-Founder | Empyrean

Serial entrepreneur with multiple patents in drug delivery, medical IT and agtech. Award winning functional beverage formulator and expert in whole food and orthomolecular formulations. Founder of 831 Cannabis Collective, MountainCraft Cannabis and co-founder of Empyrean Myco-Botanicals. Over two decades of self-use and assisting medical collective members with in-field functional bio-hacking using psilocybin, cannabis, traditional herbal medicine systems (TCM and ayurvedic) and amino acid therapies in synergy to enhance physical and mental performance, address common maladies and overcome alcohol, nicotine and opioid substance addictions.

David Nikzad

CEO | EI.Ventures

David Nikzad is the original founder of Reinmkr Satsang and original founder of Orthogonal Thinker Inc. He was the first checks in companies such as Betterment🦄, Vidyard🦄, InstantCab Ridecell🦄, Wefunder, June Software TaptoLearn, Talkable, Aisle50, TutorSpree, OrangeFund2, Quartzy, Ridejoy, GazeHawk, RealCrowd, InvoiceASAP, Meadow, Mellows, ConfidentCannabis, FOBO Yardsale, BlockRx, SericaPay, Solti, AdStage, Arcview Capital and more. He has personally incubated companies through Orthogonal SuryaSpa, KitchenNation, MauiRaw, Randy’s Remedy, EI.Ventures, Pure Mushrooms and many more.

Dr. Peter Facchini

Chief Scientific Officer | MagicMed Industries Inc.

Dr. Peter Facchini is the Chief Scientific Officer of MagicMed Industries, Inc. He has been Professor of Plant Biochemistry in the Department of Biological Sciences at the University of Calgary for 25 years. He held the Canada Research Chair in Plant Metabolic Processes Biotechnology and is currently a Parex Resources Innovation Fellow in the Faculty of Science. He has published more than 160 scientific papers and filed more than 30 patents, and is regarded as an international leader in the biochemistry and biotechnology of natural product metabolism.

Dustin Robinson

Licensed attorney, CPA, and realtor, Founder | Mr. Psychedelic Law

Licensed attorney, CPA, and realtor. Founded Mr. Cannabis Law - a full service law firm exclusively focuses on the cannabis and psychedelic space. Co-founder Mr. Psychedelic Law - a non-profit with a mission to use medical and spiritual research to drive legal reform of psilocybin mushrooms. Co-founded Mind Army - a non-profit focused on federal descheduling of psychedelics.

Susan Chapelle

President, Havn Labs| Executive VP Research & Development | Havn Life

Susan Chapelle eMBA, is an inventive leader with a highly successful career building businesses, leading as a two-term elected politician, and influencing changes that improve organizations and emergent industries. She is a published researcher in the field of wound healing and pain mechanisms. Susan is excited to open minds and bring access to human performance through her work as the Co-CEO of Havn Life Sciences.

Nadia Van der Heyden

Director of Sales and Marketing | Psygen Labs

Nadia joined Psygen in February 2020 and has developed client relationships with multiple psychedelic corporations, researchers and non-profits to provide supply chain solutions. For the last 18 years Nadia has worked on the front lines in EMS most recently as a Critical Care Flight Paramedic (CCP) qualifications and has worked in emergency retrieval medicine since 2016. Nadia's interest in psychedelic medicine (particularly for PTSD therapy and ADHD) developed from dealing with her own work-related trauma, along with an adult diagnosis of ADHD. Witnessing her first-responder colleagues suffer immensely from PTSD, high rates of suicide and addiction, she firmly believes Psygen's mission to meet the manufacturing demand of clinical trials and commercial production will promote collective healing.

Kevin Matthews

Chairman and Executive Director; President | Society for Psychedelic Outreach, Reform, and Education (SPORE); Denver Psilocybin Mushroom Policy Review Panel

Kevin led the campaign that successfully decriminalized psilocybin mushrooms in Denver, CO in May 2019. He currently serves as the Chairperson and Executive Director of the Society for Psychedelic Outreach, Reform, and Education (SPORE), and is the President of the Denver Psilocybin Mushroom Policy Review Panel. His work includes transforming public opinion about psychedelics, creating equitable access models for psychedelics, organizing community, and fostering leadership in the psychedelic ecosystem. He lives in Arvada, CO with his wife and 6 year old son.

Kelsey Ramsden

Co Founder and COO | Mind Cure Health

Twice named Canada's #1 Female Entrepreneur, Forbes says Kelsey is a master builder of ideas, businesses and sky's the limit futures. As a Co-Founder and COO of Mind Cure, Kelsey builds trust into every thing she does because individuals are trusting Mind Cure with the only mind they have - and that is an honour that must be taken very seriously. She's just as serious about being a for-runner in the revolution of mental health care during the renaissance of psychedelics and is excited about the new frontiers we are building together.

Sharan Sidhu

Science Officer & General Manager | Numinus Wellness Inc.

Sharan Sidhu is a regulatory expert and policy advisor of restrictive high growth industries, with extensive experience developing research strategy roadmaps, project plans and IP. She has worked as a hub between academia, industry and governing directorates to ensure R&D objectives meet regulatory compliance from inception to commercialization. Sharan has managed compliance projects and developed requirements for LIMS, GLP, GACP, GMP as well as done methods development, vendor qualification, ISO standards and training, development of good practices policies and quality management systems, and implementation of mass change control.

Graham Pechenik

Founder | Registered Patent Attorney, Calyx Law

A registered patent attorney, with degrees in Biochemistry and Cognitive Neuroscience, Graham spent a decade representing Fortune 500 companies in the agricultural, chemical, pharmaceutical, biotech, and technology industries before founding Calyx Law in 2016, the first patent law boutique in California to focus on cannabis and psychedelics. At Calyx Law, Graham has worked with numerous seed and early stage companies to protect their psilocybin-related IP through patent and trademark filings, and to develop IP strategies for the space. Graham also maintains the Psilocybin Patent Tracker in partnership with Psilocybin Alpha.

Jerry B. Brown, Ph.D. and Julie M. Brown, M.A., L.M.H.C.

Coauthors The Psychedelic Gospels: The Secret History of Hallucinogens in Christianity

Julie M. Brown, M.A., L.M.H.C., is an integrative psychotherapist (retired) who for 30 years worked with cancer patients using guided imagery. Jerry B. Brown is an author and anthropologist, who studies the role of sacred plants in religion. They are coauthors of The Psychedelic Gospels, 2016, and “Mystical Experience and Psychedelic-Assisted Psychotherapy: Insights from Guided Imagery Therapy with Cancer Patients” Psychedelics Today, May 28, 2020.

Paul Austin

Founder, CEO |Third Wave

Paul F. Austin is an entrepreneur, public speaker, and educator. He has founded two companies in the emerging psychedelic space, Third Wave and Synthesis. Within Third Wave, Paul leads his team in building an educational platform to ensure psychedelic substances become responsibly integrated into our metamodern cultural framework. Currently, Third Wave offers long-form psychedelic guides, online trainings focused on the skill of microdosing psychedelics, and an industry-best network of clinics and retreat providers. Because of his pioneering work at the intersection of psychedelic use, personal transformation, and professional success, Paul has been featured in the BBC, Forbes, and Rolling Stone.

Jackie Salm

Co-Founder and CSO |Psilera Bioscience

After receiving my PhD in natural products and organic chemistry, I was drawn to industries that challenged the norm. I have worked in various fields of drug discovery from neglected and tropical diseases to antibiotics to psychoactives, all of which are understudied fields with many drug discovery challenges. My father's diagnosis with a rare for of dementia and my family's struggle with addiction catalyzed my interest in neurological conditions and continues to motivate me today. Our goal with Psilera Bioscience is to find ways to accelerate research of mindful medicines whose purpose is to benefit patients as a whole and for the long term.

Gary Costner

Founder and CEO | Myco Systemics

Gary has been a psychonautic explorer of advanced neural models, theoretical physics and manifold theory most of his life. His research led him to the conclusion that 'human bodies are fruiting bodies of hyper-dimensional mycelium'. He is the patent holder of advanced 3D supercomputer architectures with extensive experience in AI and developed biological intuition synthesis algorithms in conjunction with DARPA's Polymorphic Computing Architecture project. Gary is currently focusing all of his expertise to revolutionize myco-cultivation, enabling access for all to food & medicine.

Stephen Barnhill, MD

Executive Chairman | Aion Therapeutic Inc.

Dr. Barnhill is a physician, fellowship trained in Laboratory Medicine and Board Certified by the American Board of BioAnalysis, an expert in artificial intelligence, an inventor on more than 40 patents globally and is an experienced pharmaceutical and biotech executive with experience as a CEO in both private and public companies in the United States and internationally. Previously, he was Founder, Chairman and CEO of a U.S. publicly-traded international biotech company, which he took from inception to profitability.

Eddie Jacobs

Research Fellow | University of Oxford

Eddie Jacobs is a Research Fellow at the University of Oxford's Wellcome Centre for Ethics and Humanities. Having worked on scientific and policy projects at the Beckley Foundation, a UK-based NGO that researches psychedelics, in October he began a PhD to outline the ethical challenges of psychedelic-assisted psychotherapy, how these challenges might best be met, and how they invite a reconsideration of frameworks of psychiatric practice.

Gary Heferle

Fresh from the Farm Fungi LLC

Gary is the owner of Fresh from the Farm Fungi LLC - a family owned gourmet mushroom farm in Denver, CO. His background in Medical Laboratory Science has led him to pioneer the aspects of safe growing practices in commercial cultivation and he strives to bring safety awareness to this newly evolving field of food and science. A few key factors can greatly reduce waste and improve quality and health while growing mushrooms.

Kasper Moreaux

R&D Manager | Mycelia

In 1980, I was born into the mushroom industry because the founding owner of Mycelia, Magda Verfaillie, happens to be my mother. At that time, her passion for spawn making was already the professional drive of her life. I joined Mycelia in 2010 where I have been active developing the company into what it is today: an innovative, fast-growing, flexible company with warm ambitions to develop the mushroom sector. At this moment, I am the R&D manager of Mycelia and Sac O2 and in a number of years, I will be officially taking over Magda’s role.

Tracy Komlos

Founder/CEO | The Multiverse

Tracy is a marketing and branding expert, global community builder, startup consultant and was the Founder & CEO of Pangea Dreams, the #1 industry leader in women's educational and creative retreats. She has 7+ years of experience scaling an international business in travel and wellness. Her extensive knowledge in brand partnerships, sponsorships, production, social media management and launching digitally native companies has made her a respected authority in all things digital creativity, experience design, and entrepreneurship.

Sam Chapman

Campaign Manager | Yes On Measure 109

Sam Chapman is the Campaign Manager for the Yes On Measure 109 Campaign, a statewide ballot measure seeking to create the first ever state wide regulated psilocybin therapy program in the United States. Sam has over a decade of experience in advocating for progressive drug policy reforms at the local, state, and national level. His previous experience includes consulting for statewide political campaigns, assisting local governments in writing rules and regulations, crafting and advocating for equitable access to emerging healthcare treatment options, and identifying new opportunities within emerging industries. Sam has been a resident of Oregon for 25 years. He holds a bachelor's degree from the University of Oregon in Philosophy and Political Science.

Caine Barlow

Fungi Educator, Mycologist

Caine Barlow is a fungi educator who has been cultivating and studying fungi for 14 years. In 2019 he completed a Master's degree where his research project was to predict a preliminary conservation status for many Australian fungi. When not growing fungi, Caine volunteers his time with Entheogenesis Australis, MYCOmmunity Applied Mycology, and the Australian Psychedelic Society. He writes for DoubleBlind and is also a regular contributor, “trusted identifier” and administrator on a variety of fungi oriented website forums and facebook groups.

Stefany Nieto

Chief Operating Officer | Gwella

Stefany is the Chief Operating Officer of Gwella, a company rooted in the wellness and betterment of humans through the magic of mushrooms. She is deeply committed to Toronto’s entrepreneurial ecosystem through her consulting efforts with various startups, accelerators, and in her mentorship role through the Women’s Entrepreneurship Hub.

Craig M. Trester

Applied Mycologist, Educator, & Citizen Scientist

Craig M. Trester is an educator and citizen scientist that utilizes principles of biomimicry and traditional ecological knowledge through applied mycology to develop regenerative solutions for many of the environmental challenges that impact our world. Through educational outreach he has sought to provide people with the knowledge and resources to recognize and practically apply the benefits that fungi have to offer our health, environment, and society. Aside from Craig's work as an educator much of his research focuses upon how might the qualitatively regenerative principles and techniques of permaculture be combined with the quantitatively powerful tools of molecular biology to paint a picture of the deeper ecological connections throughout nature facilitated by our microbial world. He believes novel approaches for bioremediation, carbon sequestration, and regenerative agriculture can be made a reality, through research of fungi and soil biology, diligent observation of our surroundings, and intentional application of beneficial microorganisms.

David Mokler, PhD,

Professor Emeritus at the College of Osteopathic Medicine at the University of New England

David Mokler, PhD, Professor Emeritus at the College of Osteopathic Medicine at the University of New England has 40 years of experience in neuroscience research. He studied at Michigan State University with Richard Rech examining the role of serotonin in the actions of hallucinogenic drugs. He did a post-doctoral fellowship with John Rosecrans at the Medical College of Virginia examining the effects of THC and MDMA on the brain. He spent the remainder of his career at the College of Osteopathic Medicine at UNE. He retired in 2019 but maintains an active research lab. He joined the team at HAVNlife in 2020.

Alessandra Nicole Russo

Captain | Arcana Armada

Alessandra Nicole Russo studies archetypal dynamics through a deep ecological lens. She was a founding member of Fungi Academy, a mushroom cultivation training center based in Guatemala, where she shared mushroom cultivation and laboratory skills, offered workshops on fungal ecology, medicinal mushrooms, and ethnomycology, and organized educational retreats and celebrations. She is currently based in Northern California, where she is currently developing a program to catalyze individual and collective healing through fantasy role-playing events.

Gaurav Dubey

Content Editor | Microdose Psychedelic Insights

Gaurav Dubey is a dynamic clinical biologist and evidence-based branding professional with a fervent passion for science media, public education and world travel. As the content editor for Microdose Psychedelic Insights, Gaurav is uniquely suited to combine his clinical and research background with his talents as a media professional to curate powerful multimedia content for the psychedelic space. After personally experiencing the profound impact of plant medicine, Gaurav began his pursuit in evidence-based content shifting from the lab to the laptop by creating content for the medical cannabis space. Through helping cannabis brands establish their narrative through a strategic, evidence-based approach, he gained much of the insight he applies to the emerging psychedelic landscape today.

Dr Delsa Ghorbani, BDS(Manc), MSc (Merit)(Manc)

Medical Mycologist with Clinical and Laboratory training at Wythenshawe Hospital

Dr Delsa Ghorbani BDS(Manc), MSc (Merit)(Manc) is a Medical Mycologist with Clinical and Laboratory training at Wythenshawe Hospital.

Maxillofacial and Oral Surgery Senior House Officer (DCT 1) working at Eastbourne District General Hospital- Eastbourne, Queen Victoria Hospital - East Grinstead, Uckfield Hospital- Uckfield & Conquest Hospital- Hastings. General Dentist at Dentistry For You, Eastbourne. In her free-time Dr Delsa enjoys being an Opera Singer, composer and musician and has been lucky to have performed on international television and radio. Dr Delsa is an aspiring Oral Medic with particular interest in Infectious Diseases due to her Medical Mycology background.

Alex Dorr

Founder, President and CEO | Mushroom Revival

After self curing his Lyme’s disease with mushrooms, Alex got his degree in Mycology and wrote the book “Mycoremediation Handbook: a grassroots guide to growing mushrooms and cleaning up toxic waste with fungi” (2017). He then went on to launch Mushroom Revival, an eco-friendly good for you company obsessed with the healing power of mushrooms. Alex and his team pioneered the only USDA certified Organic and largest Cordyceps militaris mushroom farm in the americas. Co hosted with his partner Lera, they launched the most popular mushroom podcast in the world “The Mushroom Revival Podcast”. Alex is on the journey to mushroom the culture around mushrooms!

Del Potter

Chief Scientific Officer | Aya Biosciences

Background is in medical anthropology (psychiatric anthropology), neuropharmacology, psychoanalysis and chemical engineering. My doctorate is in ethnopsychopharmacology, Currently, Chief Science Officer at Aya Biosciences, a biodiscovery platform for second generation psychedelic and cannabis compounds. We have a library of over 70 new compounds and are using a novel screening process to predict clinical success. We have a new psychedelic compound in preclinical that is of shorter duration and less challenging than psilocybin, with better safety and fewer adverse side effects, while keeping in place the same level of neuroplasticity.

Boaz Lehman

Co-founder and head of RnD | Kiara Naturals

Boaz embodies the vision of Kiara Naturals. Bobo is a wild man and a clinical herbalist, a nature guide and foraging instructor who is never more at home than in the embrace of nature - in a verdant valley wilderness, or under a blanket of stars on a moonless night. After completing his training in a variety of natural therapy methods, he started formulating remedies for both patients and therapists. Driven by a belief in the importance of respecting and connecting with nature, Boaz made all his remedies by foraging all the plants he used according to the season, location, moon cycles, and local traditions.

David Wasserman

Government Affairs Specialist | Conscious Consulting Co

David Wasserman has been involved in drug policy reform for over five years. He started lobbying at the state level in 2017 at the same time as he was one of the first to discuss a statewide psilocybin decriminalization effort. He was one of the founders of the statewide "Colorado for psilocybin" initiative that later became "Decriminalize Denver". He has worked on dozens of pieces of statewide legislation related to cannabis and other substances and is now focusing more on harm reduction at the local level. Prior to getting involved in policy he was an editor for Erowid.

Carmen Jackman

Intersectionality Committee Co-chair, Social Policy and Impact Co-Lead

Carmen Jackman is a Washington, D.C. area based designer, researcher, and organizer. She is the Founder and Content Manager at Butwhatabout.net and is in the UX Design M.P.S. program at the Maryland Institute College of Art (MICA). In 2012 she received a B.A. in History from the University of Maryland Baltimore County. Carmen is currently the Intersectionality Committee Co-Chair for Students for Sensible Drug Policy (SSDP) and the Social Policy and Impact Co-Lead at Intercollegiate Psychedelic Network (IPN).

David Law

Co-founder | Gourmet Mushrooms, Inc.

David Law is the co-founder of Gourmet Mushrooms, Inc. (GMI) in Sebastopol, California in 1977. GMI produces 7 varieties of culinary mushrooms and over 30 species of nutracuetical mushrooms. In 2015, GMI expanded its operations in Scottville, Michigan. David is promoting a Myco-cultural Revolution and recruiting like-minded individuals to join this movement.

Chandan Maurya

Staff Scientist University of Arkansas

Chandan Maurya is a staff Scientist in the Department of Food Science, Institute of Food Science and Engineering, University of Arkansas. His research focuses on Protein Chemistry and functionality; bio-actives value added novel food, industry by/co-products and phytochemical-pharmaceutical ingredients; new and innovative food product development and food safety integrated research.

David Satori

Mycologist & Conservation Researcher | Myceliate

David Satori is a conservationist, teacher, and an avid enthusiast of the natural world. He holds a master’s degree in Plant and Fungal Taxonomy, Diversity, and Conservation, and works as a Species Conservation Researcher at the Royal Botanical Gardens, Kew. He is the founder of Myceliate, a grassroots conservation initiative exploring how mushroom cultivation and citizen science can help bring species back from the brink of extinction. Through Myceliate, he offers mushroom cultivation workshops, foraging walks, and a suite of engaging talks in the world of mycology. He has had the opportunity to speak at various events, including King’s College London, where he gave a talk on the potential of fungi to decompose pollution in the environment.

Julia Mirer MD

Consultant

After growing disheartened with the medical system, I resigned from my Pediatric Residency to pursue alternative healing paths. This exploration led me to discover the unbelievable healing potential of psilocybin, and began my 2 year journey of learning how to speak about these medicines to begin to break the stigma, increase awareness, and advocate for the responsible reintegration of psychedelics into society as well as clinical practice. My passion is to empower through education, teaching people to take their health (especially mental health) back into their own hands. My goal is to facilitate reform, so that we can all begin to heal and work together for a better future.

David Wood

Partner | Borden Ladner Gervais LLP

David is co-chair of Borden Ladner Gervais' Cannabis Industry Focus Group and his practice focuses on intellectual property and regulatory law. His practice is focused entirely on work with psychedelics, entheogens, dissociative anaesthetics and other controlled substances, and on the global cannabis industry. David works with innovators in the emerging psychedelics space and in the global cannabis industry. David holds a PhD in structural biochemistry, which provides useful insight and perspective when advising clients.

Ian Bollinger

Founding Partner & Entheogen Reearcher | Critical Consulting

A driven biologist with extensive clean-room lab experience in biochemistry, molecular biology, and plant biotechnology. Has utilized his background and inquisitiveness to support the growing Cananbis regulatory market, and works to support other burgeoning entheogen markets with solid research to inform future regulations.

Natasha de Jong

Chief Earth Office | Earth Resonance

With Earth Resonance we are offering microdosing with a natural source of psilocybin for personal, spiritual and therapeutical benefits. Microdosing with Earth Resonance means following our 30-days Protocol to transform your life. Intention setting, self-reflective questions, meditiation, breathwork and Resonance hacks help you to align to your true self, reduce stress and help you to find balance from within. Earth Resonance is located in the Netherlands and working together with industry leaders with more than 20 years of experience in the field of cultivating fresh psychedelic sclerotia. We are happy to share our integrated approach, testimonials of transformation and are looking forward to speak to you about the revolution of consciousness with psychedelics, mushroom and healing frequencies.

Jon Kostakopoulos

Chairman & President | Apollo Pact, Inc.

Jon Kostakopoulos was the first study participant for NYU's clinical trial for alcoholism. Prior to enrolling, Jon tried every treatment available, to no avail. He then participated in NYU's trial, and he hasn't had a drink since his first psilocybin session in 2015. Since leaving the trial, Jon formed a nonprofit, Apollo Pact, to fund psilocybin research and advocate for this treatment which has the potential to solve the mental health crisis. Jon was a news anchor during the clinical trial, and as a journalist was aware how big of a story this would be if it were successful. Anderson Cooper interviewed Jon for his "60 Minutes" story on psilocybin, which garnered Jon national attention.

Oriana Mayorga

Vice Chair of the Board of Directors | Students for Sensible Drug Policy

Oriana (she/her/ella) is a cis-femme first generation, anti-oppression organizer and harm reductionist from New York. She currently serves as the Vice Chair of the Board Directors at Students for Sensible Drug Policy (SSDP), where she also co-chairs the Intersectionality Committee. Oriana is dedicated to dismantling structural oppression, promoting racial justice, ending violence against women and advancing harm reduction practices. She is a longtime advocate of ending the war on drugs and centering the needs of people of color in psychedelia.

Jonathan Bernard

Owner, farmer, operator | Jon's Gourmet Mushrooms, Inc.

Vertical farmer & business owner in the urban farming industry. Started my career at Square Roots farming greens vertically & hydroponically, which subsequently evolved into farming gourmet mushrooms. I now own & operate a small scale mushroom farm located in New York, selling to restaurants, farmers markets & home delivery. I began in 2016, and have learned quite a bit since then. My expertise lies in growing mushrooms, building a business, finding & expanding relevant markets & scaling.

Dr. Paula-Noel Macfie, Indigenous Scientist/Decolonizing Methodologist/Back Door Medicine LLC

Owner/Researcher/Inventor | Back Door Medicine LLC

I am an Indigenous Science researcher specializing in decolonizing methodologies and traditional knowledge with a PhD in Recovery of Indigenous Mind. I serve on two subcommittees of Oregon Cannabis Commission - Research and Patient Equity. I am the owner of Back Door Medicine, LLC a research-based business that educates people globally on the use of cannabis suppositories. I am also an inventor and recently received a patent for my suppository mold for people with disabilities to be make their own plant medicine. I am a member of the Oregon Native American Chamber in Portland, Oregon. I am Tuatha and Dalriadian from Clan Macdhubhsidhe.

Joshua Simone

Founder | Pitriya

Joshua has started a company called Pitriya that brings fungi to the forefront of science, medicine, and technology. Born near Chicago, IL and graduate of Kelley School of Business at Indiana University in May 2018, he is currently working in the gourmet and medicinal mushroom industry as well as researching and collaborating with psychedelic researchers, farmers, wild harvesters and clinicians. In his spare time, you can find him studying Jewish law, philosophy and history in Long Island, New York.

Paula Kahn

Community Sponsorship & Decarceration Strategist | Freedom For Immigrants | Cosmovisiones Ancestrales

Paula (she/they) is Community Sponsorship and Decarceration Strategist at Freedom for Immigrants, co-founder of Cosmovisiones Ancestrales, and a performance artist. Paula weaves liberatory networks at the intersections of indigenous rights, drug policy, feminism, historical memory, demilitarization, racial, migrant, environmental, & healing justice. Paula studies herbalism, mycology, & uses of psychoactive substances for individual and collective healing processes. Paula is an advocates for reparations for survivors of state violence through access to psychedelic assisted, traditional, hybrid, and emerging therapies.

Psil Silva

Psychedelic Researcher & Writer | Psil Silva

Psil Silva created Psilocybin Stories in 2020 after ten years of personal experience with psilocybin. On his Psilocybin Stories website he shares his and others’ psychedelic stories with an emphasis on introspective insights that empower. He received his M.Ed. in 2015 and now specializes in psychedelic research, writing, and integration. He looks forward to continually exploring the limitless psychedelic realm with interested psychonauts.

Robin Manzanos-Banister

Psychotherapist and Mental Wellness Director | Rise Wellness Retreats

A bilingual (English and Spanish) psychotherapist with a private practice in Toronto, as well as the Mental Wellness Director and founding member of Rise Wellness retreats. These retreats based in Jamaica are focused on teaching and implementing holistic wellness practices. We also incorporate micro-dosing psilocybin as part of that wellness journey, as well as the option for larger dose ceremonies. I would love the opportunity to present or sit on a panel discussing the importance of preparation and integration of psychedelic experiences, from both a microdose or high dose experience. I previously participated in Mapping the Minds on a panel discussing 'New Advancements in Psychedelic Integration" and really enjoyed the experience.

Stephanie Price

Journalist & Editor

Stephanie is a health journalist covering the science, research, policy and developments in the world of cannabis and psychedelic medicines.

Sabrina Frometa

CEO | YAYA

Sabrina Frometa, daughter of Calixto Frometa and Ana Rita Ventura, who both migrated from the Ayiti/Dominican Republic is the Founder of YAYA. YAYA is an ecosystem of creators, organizers, facilitators and dreamers committed to the liberation. Currently, Sabrina serves as Director of Equity, Operations and Culture for SPORE, the Society for Psychedelic Outreach, Reform and Education. Sabrina is called to action by ancestral wisdoms of communities of color, which brings her to this work of building towards psychedelic justice. Committed to ecological justice, leadership and joy, among other things, Sabrina is also writing this bio as an emerging healer, modern dancer, laughing queen and recovering, latch-key kid from Bushwick, Brooklyn.

Sam Gandy

Research collaborator, designing nature-based practices on behalf of Synthesis | Synthesis Institute / Centre for Psychedelic Research, Imperial College London

Sam is a lifelong nature lover with a PhD in ecological science from the University of Aberdeen and an MRes in entomology from Imperial College London. He is a writer and speaker and has experience working within the psychedelic field, as a past scientific assistant to the director of the Beckley Foundation, and is currently working as a collaborator with the Centre for Psychedelic Research at Imperial College London. His research is focused on the capacity of psychedelics to (re)connect our increasingly disconnected species to nature, for the potential betterment of humanity and the biosphere at large. Sam currently works at the Synthesis Institute designing individually tailored nature-based practices for people undergoing psilocybin therapy for depression.

Sabrina Ramkellawan

Chief Operations Officer; President | Knowde Group Inc; Clinical Research Association of Canada

Sabrina Ramkellawan started her career as a registered nurse and has over 20 years of clinical trial experience (phase I-IV) in pharma, medical devices, natural health products and plant-based therapeutics. She has held positions at or advised some top pharmaceutical, cannabis, psychedelic, and research companies. She has previous experience leading operations at large scale global Contract Research Organizations including INC Research (now Syneos Health). In her role as Chief Operating Officer at Knowde Group, she is focused on all operational aspects of conducting research specializing in plant-based therapeutics including psychedelics.

Stephanie Hope

Doctor of Nursing Practice, RN, Health Coach | Hope Holistic Wellness

Dr. Stephanie Hope is a Doctor of Nursing Practice, registered nurse, and certified nurse coach. She worked as a study guide on NYU's Psilocybin Cancer Anxiety trial and has been intensively studying sacred medicine traditions for the last decade. Stephanie is keenly interested in the care of patients undergoing psychedelic experiences and in developing what the profession of nursing, based on the art and science of caring, can bring to the emerging practice of psychedelic care.

Seth Rosenberg

Advocate/Cultivator | District Psychedelic

Seth Rosenberg is a Washington, DC native and an avid amateur mycologist, an advocate for the responsible use of psychedelics and producer of The Capital Psychedelic Summit. He is also the proud father of a second grader , and when he isn’t working, he can usually be found in the woods foraging with her.

Sophie-Charlotte Adler

Psychologist and Hypnotherapist | ACS MINDWORKS

Sophie-Charlotte Alice Adler, MSc, is a psychologist, hypnotherapist, researcher and author. She has specialized in working with altered states of consciousness and has been guiding ketamine infusion therapies in a private clinic in Mallorca since 2018, where she developed an innovative therapy method - the "Ketamine Hypnosis Package" (KHP). She also works as a lecturer for medical hypnosis and ketamine therapy in this field. Sophie wrote her master thesis about the potential of psilocybin for modern therapy in research and practice wich has been published at Carl Auer Publisher in Germany this year. She is also the founder of ACSMINDWORKS - a geographically-independent group of specialists who are involved in healing in a variety of ways and work together as a "Healing Crew" with a focus on integration, creativity, closeness to nature and community (www.acsmindworks.com). She is a member of the MIND Foundation and the KRIYA-Consultation Group with Dr. Raquel Bennett and Dr. Jessica Katzman.

Julia Perederiy, PhD

Lead Scientist | Pilz Bioscience, Corp.

Specializing in early-stage technologies and data-driven corporate strategy, Dr. Julia Perederiy holds scientific and commercialization expertise along the full spectrum of biological innovation, from single-cell analytics to systems-level therapeutics. An established academic scientist, Dr. Perederiy is an author of multiple peer-reviewed publications, including highly regarded research on the neurogenetics of autism. In the private sector, Julia is an experienced entrepreneur and management consultant, helping biotechnology companies with business planning, market entry strategy, and fundraising. Dr. Perederiy holds Bachelor’s degrees in Neurobiology and Psychology from the University of California, Berkeley, a Master’s in Technology Entrepreneurship from University of Portland, and a PhD in Neuroscience from Oregon Health & Science University.

Irie Selkirk

Co-Founder | Rise Wellness & Sansero Life Sciences

Irie Selkirk is the co-founder and Director of Rise Wellness Retreat in Jamaica, co-founder of Sansero Life Sciences - a psilocybin bioscience company based in Canada, co-founder of the MAPS Canada Toronto Support Chapter, and the Chief Communications Officer for SheCann Cannabis - a female focused medical cannabis advocacy group. She is an expert on patient care and acquisition focused on psychedelics, natural and plant medicines.

Dr. Emily Kulpa

PharmD | Consultant

Dr. Emily Kulpa is a clinical pharmacist in Milwaukee, WI. She provides holistic wellness services to optimize mental wellness and overall well-being. She believes that pharmacists have an important role in psychedelic-assisted therapies when it comes to identifying drug-drug interactions, minimizing adverse effects and antidepressant tapering regimens. She has worked at Synthesis Institute as the Director of Medical Screening and for the Canadian Centre for Psychedelic Science as Head Pharmacist and Research Associate.

Veronica Castillo

Publisher- Editor- Writer

Veronica Castillo is a Writer from Miami, with a pre-Cannabis background in insurance and human resources. Currently, she is a resident of the road on an exploration of all thing’s cannabis and hemp in the United States, with plans to leave the U.S to explore Cannabis and hemp abroad. Veronica’s mission is to educate, inform, and destigmatize because she believes in the power of love for all plant medicine.

Tyler Bryden

Owner | Speak AI Inc.

Tyler Bryden is a graduate of Western University and Fanshawe College, where he studied interactive media and the effects of evolving technology in people’s lives and businesses. A passionate speaker, psychedelics advocate and avid learner, Tyler continues to integrate emerging technologies into services and products in hopes to make a better world for himself, his clients, and the community.

Gabby Agin-Liebes

Research Fellow | UC San Francisco

Gabby Agin-Liebes is currently a National Institute on Drug Abuse (NIDA)-funded postdoctoral fellow at Weill Institute for Neuroscience, Department of Psychiatry, UCSF. She received her PhD in clinical psychology from Palo Alto University. Her doctoral research focused on the clinical applications of psilocybin-assisted therapy and mindful self-compassion-based interventions to treat mood, substance use, and trauma-based disorders. Prior to her graduate studies, Gabby served as the lead project manager of the NYU Psychedelic Research Group. Gabby is a passionate promoter of the ethical and responsible use of psychedelic medicines and their accessibility to underserved populations.

The Conscious Fund invests in early stage ventures in plant powered medicine. We are helping the psychedelic medicine space to grow ethically and sustainably through our work with Seed to Series A companies.

Media Partners

Psyindex is a media partner with the leading psychedelics index, powered by CFN Enterprises Inc. (OTCQB: CNFN). A leading agency and financial media network dedicated to the cannabis industry, CFN helps private, pre-public and public cannabis companies in the US and Canada attract capital, investors and media attention.

The Third Wave is dedicated to educating individuals about responsible psychedelic use within the context of optimal mind-body-spirit wellness.

Their Mission is to facilitate the world’s adoption of psychedelics as a catalyst for personal development and collective well-being.

Their Vision is to co-create a global culture that embraces psychedelics as necessary tools for healing and transformation.

Hub News is a bi-monthly digital magazine for anyone with an interest in healthcare.  Sharing best practice, news, case studies and valuable insight, this interactive resource is sent directly to the inbox of subscribers.  Subscribe for free.   

Psilocybin Alpha is the definitive resource for investors in the emergent psychedelic medicine sector. Cut through the noise with breaking news, exclusive interviews, industry data and curated private financing opportunities.

Here at PsiloHealth, we cultivate a value-based model to empower individuals and communities through education, legislation and integration. We provide a thoughtful client-led approach that supports the safe and effective use of psilocybin with equitable access at the forefront.

A ‘Free Press’ is perhaps one of the most important community resources for living happy, healthy and abundant lives. This seemingly simple resource of that same community having a shared voice, a place where one can be heard, truth shared, public notices made, awareness encouraged and explored, knowledge pooled, wisdom combined, discussions, and yes, grievances aired, where people and their businesses can actually become liberated in the traditional yet practically non-existent form of true free-markets, cannot be overstated.

We’ve elected to govern ourselves. In the pages of our New Agora, both in print and online, we’ve invited and encouraged others to do the same for themselves rather than abrogate that all important and very personal responsibility to others, to thereby avoid the chaos and predation, the hierarchical parasitism empowered by that very same abrogation of personal responsibility for self-governance.

Truth is our Currency. Elect to Govern Yourself. www.newagora.ca Past 10 Years New Agora Newspaper. Now Online. Launching our New Now Magazine.

Pharmacists Connect is a networking and education site for pharmacists. Currently over 850 members via the Slack networking platform.

ABOUT OUR EVENTS

Since hosting the Virtual Psychedelic Conference where over 1,000 people gathered to hear 100+ speakers over 2 days, we recently hosted the Ketamine Conference as our first Molecular Masterclass.

In addition, we now host ongoing series such as Psychedelic Capital, Psychedelics &, plus various podcast circuits where our speakers/sponsors showcase to the diverse Microdose network of UHNWIs, Analysts, Family Offices, Scientists, VCs, International Firms, PE & Funds, and a variety of specific niches. Through these events, we’ve built an audience of thousands of investors and international professionals working or interested in psychedelics.

BECOME A SPONSOR

Selected sponsors have the unique opportunity to gain access to our full digital marketing and PR suite, placing their brand in front of 110,000+ customers, decision-makers and influencers.

Leading sponsors will also have the opportunity to personally connect with investors and multinational corporates through 1-on-1 investor briefings. Please email kristina@microdose.buzz for further details.

TICKETS

All tickets are offered on a first-come first-served basis. If you are an accredited or high net worth investor, please contact us for a complimentary ticket at info@microdose.buzz

If you are an accredited member of the press, please contact us for a media pass at info@microdose.buzz

* Please note that companies and speakers may change from time to time. The sector is so busy that we occasionally have to make amendments on short notice.